国联民生证券承销保荐有限公司 关于北京富吉瑞光电科技股份有限公司 首次公开发行股票募集资金投资项目结项并将部分节余募 集资金永久补充流动资金的核查意见 国联民生证券承销保荐有限公司（以下简称"国联民生保荐"或"保荐机构"） 作为北京富吉瑞光电科技股份有限公司（以下简称"富吉瑞"或"公司"）首次 公开发行并在科创板上市的持续督导保荐机构，根据《证券发行上市保荐业务管 理办法》《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上市公 司自律监管指引第 1 号——规范运作》《科创板上市公司持续监管办法（试行）》 及《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》等 有关法律法规和规范性文件的规定，对富吉瑞首次公开发行股票募集资金投资项 目结项并将部分节余募集资金永久补充流动资金的事项进行了核查，具体情况如 下： 一、募集资金基本情况 （一）基本情况 根据中国证券监督管理委员会（以下简称"中国证监会"）于 2021 年 8 月 31 日出具的《关于同意北京富吉瑞光电科技股份有限公司首次公开发行股票注册的 批复》（证监许可〔2021〕2820 号），同意公司首次公开发行股票的注册申请。公 ...

北京云亭律师事务所 关于北京富吉瑞光电科技股份有限公司 2022 年限制性股票激励计划之作废部分已授予尚未 归属的限制性股票相关事项的 法律意见书 关于北京富吉瑞光电科技股份有限公司 2022 年限制性股票激励计划之作废部分已授予尚未归属的限制性股票相关事项 的法律意见书 北京市朝阳区建国路 126 号瑞赛大厦 16/17/18 层(邮编:100020) 电话:+86 10 5944 9968 16/17/18F, Raise Plaza, No. 126 Jianguo Road, Chaoyang District, Beijing 100020, China Tel: +86 10 5944 9968 北京云亭律师事务所 云亭律证字[2025]FJR-1 号 致:北京富吉瑞光电科技股份有限公司(以下称"富吉瑞"或"公司") 根据《中华人民共和国公司法》(以下称"《公司法》")、《中华人民共和国证 券法》(以下称"《证券法》")、《上市公司股权激励管理办法》(以下称"《管理办 法》")《科创板上市公司自律监管指南第 4 号 -- 股权激励信息披露》(以下称 "《4 号指南》")等有关法律、法规、规章及规范 ...

北京富吉瑞光电科技股份有限公司 2024 年度独立董事述职报告 2024年，作为北京富吉瑞光电科技股份有限公司（以下简称"公司"）的独 立董事，严格按照《中华人民共和国公司法》《中华人民共和国证券法》《上海 证券交易所科创板股票上市规则》等相关法律、法规，以及《公司章程》《独立 董事工作制度》等规定，本着真实、独立、客观、公正的原则，谨慎、勤勉地履 行独立董事的职责，积极出席相关会议，认真审议各项会议议案，切实维护公司 和股东特别是中小股东的合法权益。现将2024年度履职情况报告如下： 一、独立董事的基本情况 （一）工作履历、专业背景以及兼职情况 廖宁放先生，1960年1月出生，中国国籍，无境外永久居留权，博士学历。 1989年5月至1992年12月，任职昆明物理研究所工程师；1993年1月至1999年8月， 先后任云南师范大学物理系副教授、教授；1999年9月至2001年8月，任清华大学 精仪系博士后；2001年9月至今，任北京理工大学光电学院教授；2020年9月至今， 任本公司独立董事。 （二）独立性说明 作为公司的独立董事，本人及关系密切的家庭成员均不在公司或其附属企业 任职；没有直接或间接持有公司股份 ...

北京富吉瑞光电科技股份有限公司 2024 年度独立董事述职报告 2024年，作为北京富吉瑞光电科技股份有限公司（以下简称"公司"）的独 立董事，严格按照《中华人民共和国公司法》《中华人民共和国证券法》《上海 证券交易所科创板股票上市规则》等相关法律、法规，以及《公司章程》、公司 《独立董事工作制度》等规定，本着真实、独立、客观、公正的原则，谨慎、勤 勉地履行独立董事的职责，积极出席相关会议，认真审议各项会议议案，切实维 护公司和股东特别是中小股东的合法权益。现将2024年度履职情况报告如下： 一、独立董事的基本情况 （一）工作履历、专业背景以及兼职情况 作为公司的独立董事，本人及关系密切的家庭成员均不在公司或其附属企业 任职；没有直接或间接持有公司股份、不在公司前十大股东、直接或间接持有公 司已发行股份5%或以上的股东单位任职。没有为公司及其控股股东、实际控制人 或者其各自附属企业提供财务、法律、咨询等服务。具有法律法规、《公司章程》 及公司《独立董事工作制度》所要求的独立性和担任公司独立董事的任职资格， 能够确保客观、独立的专业判断，故不存在影响独立性的情况。 二、独立董事年度履职概况 （一）2024年度出 ...

北京富吉瑞光电科技股份有限公司 （一）工作履历、专业背景以及兼职情况 凌永平先生，1970年1月出生，中国国籍，无境外永久居留权，研究生学历， 中国注册会计师，中国注册税务师，国际注册高级会计师，纳税筹划师，曾任职 于赣州银行、赣州华昇会计师事务所、深圳市美之电实业有限公司；2016年11 月至2022年10月任深圳市明微电子股份有限公司独立董事；2019年6月至2022年 12月任维峰电子（广东）股份有限公司独立董事；2023年8月至2025年2月任深圳 市时代高科技设备股份有限公司独立董事。2011年至今为亚太鹏盛税务师事务所 股份有限公司合伙人；2019年12月至今为鹏盛会计师事务所（特殊普通合伙）合 伙人；2021年4月至今任深圳宏业基岩土科技股份有限公司独立董事；2023年12 月至今任北京福石控股发展股份有限公司独立董事；2023年7月至今任本公司独 立董事。 （二）独立性说明 作为公司的独立董事，本人及关系密切的家庭成员均不在公司或其附属企业 任职；没有直接或间接持有公司股份、不在公司前十大股东、直接或间接持有公 司已发行股份5%或以上的股东单位任职。没有为公司及其控股股东、实际控制人 或者其各 ...

Financial Performance - The company achieved a net profit attributable to shareholders of 11.639 million yuan for the year 2024, while the parent company reported a net loss of 17.0974 million yuan[6]. - In 2024, the company achieved operating revenue of RMB 30,227.19 million, a 44.4% increase compared to RMB 20,933.41 million in 2023[22]. - The net profit attributable to shareholders was RMB 1,163.90 million, marking a turnaround from a loss of RMB 9,631.87 million in 2023[24]. - The net profit after deducting non-recurring gains and losses was RMB 947.67 million, also a recovery from a loss of RMB 9,755.42 million in the previous year[24]. - The company's cash flow from operating activities was RMB 2,923.99 million, an 8.52% increase from RMB 2,694.50 million in 2023[22]. - The total assets at the end of 2024 were RMB 73,638.54 million, a 9.95% increase from RMB 66,972.77 million in 2023[22]. - The basic earnings per share for 2024 was RMB 0.15, compared to a loss of RMB 1.27 per share in 2023[23]. - The gross margin for infrared thermal imaging products increased by 16.17 percentage points to 42.82%[129]. - The company achieved a total revenue of 3,756.6 million RMB, with a net profit of 1,019.8 million RMB, reflecting a significant increase in performance compared to the previous period[95]. Research and Development - Research and development expenses accounted for 16.74% of operating revenue, a decrease of 17.95 percentage points from 34.69% in 2023[23]. - The total R&D expenditure decreased by 30.30% year-on-year, amounting to ¥5,060.86 million, primarily due to the ongoing validation phase of fundraising projects[84][86]. - The company has filed for 8 new patents during the reporting period, bringing the total number of authorized patents to 132, including 22 invention patents[83]. - The company has developed a full-process independent design and development capability for non-cooling infrared detectors, including CMOS readout circuit chips and MEMS infrared sensing chips[47]. - The company has made continuous investments in R&D, focusing on optimizing non-cooling infrared detector products and enhancing core components of thermal imaging products[80]. - The company has established partnerships with several well-known research institutions and universities, enhancing its technological innovation capabilities[103]. - The company is focused on integrating various technologies, including optics, electronics, and algorithms, to enhance product design and competitiveness[104]. Market and Product Development - The company plans to continue expanding its market presence and optimizing management strategies to sustain growth[25]. - The company is focusing on expanding its product matrix in the non-infrared optical field, launching new products such as quantum encryption cameras and laser communication systems[37]. - The company is positioned in a rapidly growing infrared thermal imaging industry, with significant future market demand and development prospects[58]. - The company is actively developing new products and expanding sales channels to mitigate customer concentration risks[115]. - The company aims to focus on infrared thermal imaging technology and expand into solid-state micro-light, short-wave, laser, and visible light fields over the next three to five years[156]. - The company is exploring potential acquisitions to enhance its product portfolio, with a focus on companies specializing in optical technology[177]. Corporate Governance and Compliance - The company has received a standard unqualified audit report from its accounting firm, ensuring the accuracy and completeness of its financial statements[6]. - The company has established a quality management system that has passed certifications such as GB/T19001-2016 and GJB9001C-2017, ensuring long-term product quality stability[109]. - The company has implemented measures to control accounts receivable risks, which have grown alongside sales, to ensure effective management[118]. - The company has improved investor relations management, utilizing multiple channels for communication with investors[169]. - The company strictly adhered to information disclosure obligations, ensuring timely and accurate announcements during the reporting period[170]. Employee and Management - The company has a total of 264 employees, with 102 in R&D, representing approximately 38.64%[36]. - The average salary for R&D personnel was 3,355.42 million RMB, reflecting the company's investment in talent retention and development[98]. - The company has implemented a performance-based salary system for 2024, focusing on project-based assessments and optimizing R&D cost efficiency[197]. - Total remuneration for all directors, supervisors, and senior management at the end of the reporting period amounted to 808.13 million yuan[184]. - The company appointed a new general manager and board secretary, Huang Fuyuan, and a new board secretary, Zhang Daway[185]. Risks and Challenges - The company faces a risk of core component procurement dependency, with external purchases of detectors increasing costs by approximately 18-25% compared to self-supply[116]. - The company is exposed to market competition risks that may lead to significant price declines in infrared thermal imaging products[113]. - The company is addressing inventory risks by enhancing procurement and production management to reduce potential write-downs[119]. - The company has reported no significant changes in competitive conditions that would adversely affect its operations[171].

Financial Performance - The company's operating revenue for Q1 2025 was ¥45,438,251.53, a decrease of 40.51% compared to ¥76,374,116.71 in the same period last year[4]. - The net profit attributable to shareholders was -¥10,641,181.25, representing a decline of 244.56% from a profit of ¥7,361,176.28 in the previous year[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥10,680,929.97, down 247.83% from ¥7,225,057.38 year-on-year[4]. - The basic and diluted earnings per share were both -¥0.14, a decrease of 240% compared to ¥0.10 in the same period last year[4]. - The weighted average return on equity was -2.14%, a decrease of 3.62 percentage points from 1.49% in the previous year[4]. - The company reported a net loss of RMB 76,655,122.79 for the period, worsening from a loss of RMB 66,013,941.54 in the previous period[15]. - Operating profit for Q1 2025 was a loss of ¥10,592,129.34, compared to a profit of ¥7,386,756.99 in Q1 2024[18]. - Net loss for Q1 2025 was ¥10,641,181.25, compared to a net profit of ¥7,361,176.28 in Q1 2024[20]. Cash Flow - The net cash flow from operating activities was -¥41,715,316.43, compared to -¥29,138,911.54 in the same period last year, indicating a worsening cash flow situation[4]. - Cash flow from operating activities for Q1 2025 was a net outflow of ¥41,715,316.43, compared to a net outflow of ¥29,138,911.54 in Q1 2024[22]. - Cash flow from investing activities for Q1 2025 was a net outflow of ¥774,634.24, compared to a net outflow of ¥15,509,249.48 in Q1 2024[23]. - Cash flow from financing activities for Q1 2025 was a net inflow of ¥30,922,298.09, significantly up from ¥2,842,175.69 in Q1 2024[23]. - The company reported cash and cash equivalents at the end of Q1 2025 of ¥211,465,608.59, compared to ¥197,057,113.26 at the end of Q1 2024[23]. Research and Development - Research and development expenses totaled ¥11,446,366.07, down 26.91% from ¥15,660,473.31 year-on-year[4]. - Research and development expenses for Q1 2025 were ¥11,446,366.07, down 27% from ¥15,660,473.31 in Q1 2024[18]. - The proportion of R&D expenses to operating revenue increased to 25.19%, up 4.69 percentage points from 20.50% in the previous year[5]. Assets and Liabilities - Total assets at the end of the reporting period were ¥748,692,214.98, an increase of 1.67% from ¥736,385,404.96 at the end of the previous year[5]. - The company's current assets totaled RMB 628,751,288.44, up from RMB 613,005,171.01, indicating an increase of about 2.9%[13]. - Cash and cash equivalents decreased to RMB 211,465,608.59 from RMB 223,033,426.04, representing a decline of approximately 5.5%[13]. - Accounts receivable rose to RMB 228,890,464.02 from RMB 203,305,398.03, marking an increase of around 12.6%[13]. - The company's total liabilities increased to RMB 255,413,023.93 from RMB 233,086,315.08, which is an increase of about 9.6%[15]. - Short-term borrowings increased significantly to RMB 95,064,856.36 from RMB 60,043,704.16, reflecting a rise of approximately 58.3%[15]. - The total equity attributable to shareholders decreased to RMB 493,279,191.05 from RMB 503,299,089.88, a decline of about 2%[15]. - Shareholders' equity attributable to shareholders was ¥493,279,191.05, a decrease of 1.99% from ¥503,299,089.88 at the end of the previous year[5]. - Inventory levels increased slightly to RMB 165,084,544.10 from RMB 160,807,992.36, showing a growth of about 2.1%[13]. Product Development - The company has not reported any significant new product launches or technological advancements during this period[11].

RSM 容诚 募集资金存放与实际使用情况鉴证报告 北京富吉瑞光电科技股份有限公司 容诚专字[2025]230Z0363 号 容诚会计师事务所(特殊普通合伙) 中国北京 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://zqc.mof.gov.cn）" 进行 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http:///z 报告编码:京258CfPUC 页码 内 容 序号 1-2 募集资金存放与实际使用情况鉴证报告 1 l-5 2 募集资金存放与实际使用情况的专项报告 目 录 · 募集资金存放与实际使用情况鉴证报告 容诚专字[2025]230Z0363 号 北京富吉瑞光电科技股份有限公司全体股东: 我们审核了后附的北京富吉瑞光电科技股份有限公司(以下简称富吉瑞)董 事会编制的 2024 年度《募集资金存放与实际使用情况的专项报告》。 一、对报告使用者和使用目的的限定 本鉴证报告仅供富吉瑞年度报告披露之目的使用，不得用作任何其他目的。 我们同意将本鉴证报告作为富吉瑞年度报告必备的文件,随其他文件一起报送并 对外披露。 五、鉴证结论 我们认为，后附的富吉瑞 2024 年度《募集资金 ...

根据中国证券监督管理委员会《上市公司独立董事管理办法》《上海证券 交易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管指引 第 1 号——规范运作》等要求,北京富吉瑞光电科技股份有限公司（以下简称 "公司"）董事会，就公司在任独立董事凌永平、廖宁放、王慧的独立性情况 进行评估并出具如下专项意见: 北京富吉瑞光电科技股份有限公司董事会 关于独立董事独立性自查情况的专项报告 经核查独立董事凌永平、廖宁放、王慧的任职经历以及相关自查文件，上 述人员未在公司担任除独立董事以外的任何职务,也未在公司主要股东公司担 任任何职务，与公司以及主要股东之间不存在利害关系或其他可能妨碍其进行 独立客观判断的关系,不存在影响独立董事独立性的情况，符合《上市公司独 立董事管理办法》《上海证券交易所科创板上市公司自律监管指引第 1 号—— 规范运作》中对独立董事独立性的相关要求。 北京富吉瑞光电科技股 ...

证券代码：688272 证券简称：富吉瑞 公告编号：2025-022 北京富吉瑞光电科技股份有限公司 关于首次公开发行股票募集资金投资项目结项 并将部分节余募集资金永久补充流动资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 北京富吉瑞光电科技股份有限公司（以下简称"公司"或"富吉瑞"）于 2025 年 4 月 24 日召开第二届董事会第十八次会议和第二届监事会第十一次会议， 审议通过了《关于首次公开发行股票募集资金投资项目结项并将部分节余募集 资金永久补充流动资金的议案》，同意将募集资金投资项目"光电研发及产业 化建设项目""研发中心建设项目""非制冷红外探测器研发及产业化建设项 目""工业检测产品研发及产业化建设项目"予以结项，并将节余募集资金中 的 5,000 万元用于永久补充公司流动资金。公司监事会发表了明确同意的意见， 保荐机构华英证券有限责任公司（现已更名为"国联民生证券承销保荐有限公 司"，以下简称"国联民生保荐"或"保荐机构"）对该事项出具了明确的核 查意见。该事项在董事会审批权限范围内，无需提交 ...